We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Culture-Based High Throughput Screen Detects Potent Anti-Ovarian Cancer Drugs

By LabMedica International staff writers
Posted on 23 Feb 2015
Print article
Image: The micrograph shows a multilayered three-dimensional \"organotypic\" platform for quantitative high-throughput screening to identify new therapeutics for ovarian cancer. Fibroblasts are red. Mesothelial cells are blue. Ovarian cancer cells are green. The square image is the XY-planes (up-down, right-left). The images on the sides are Z-planes (depth) (Photo courtesy of Lengyel laboratory, University of Chicago).
Image: The micrograph shows a multilayered three-dimensional \"organotypic\" platform for quantitative high-throughput screening to identify new therapeutics for ovarian cancer. Fibroblasts are red. Mesothelial cells are blue. Ovarian cancer cells are green. The square image is the XY-planes (up-down, right-left). The images on the sides are Z-planes (depth) (Photo courtesy of Lengyel laboratory, University of Chicago).
Cancer researchers have developed a high throughput system for screening drugs against ovarian tumors that is based on inhibition of cancer cells growing in a three-dimensional culture system.

Most high throughput screening (HTS) assays for drug discovery use cancer cells grown in monolayers despite the fact that the tumor microenvironment is known to contribute to cancer metastasis and drug resistance. To incorporate the tumor microenvironment into the drug screening process, investigators at the University of Chicago (IL, USA) coated the wells of 384- and 1,536-well microtiter plates with a multilayered cellular mixture containing primary human fibroblasts, mesothelial cells, and extracellular matrix. Cultures of fluorescently labeled ovarian cancer cells from three different lines (HeyA8, SKOV3ip1, and Tyk-nu) were added to the wells and then exposed to a library of small-molecule compounds. The numbers of adhering and invasive ovarian cancer cells were counted, and the inhibitory potential of each compound evaluated.

Results published in the February 5, 2015, online edition of the journal Nature Communications revealed that in the initial screen of 2,420 compounds there were 17 compounds that inhibited cell adhesion and invasion by at least 75%. Six of these compounds were active in a dose-response relationship in all three ovarian cancer cell lines, and four compounds significantly inhibited key ovarian cancer cell functions in the early steps of metastasis at low doses. One of the compounds, beta-escin, which is isolated from the seeds of the Chinese horse chestnut, was found to inhibit tumor growth and metastasis by 97%.

"Visualizing how cancer cells interact with a tumor microenvironment that accurately reflects the complex biology of ovarian cancer should help us understand the mechanisms underlying metastatic progression as well as identify new therapeutics that can inhibit this process," said senior author Dr. Ernst Lengyel, professor of obstetrics and gynecology at the University of Chicago. "We think this novel screening system has the potential to uncover new, more effective medications that could be targeted more specifically at a patient's cancer."

Related Links:

University of Chicago


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.